secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalon GloboCare Corp. (ALBT)
CIK:        0001630212
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001213900-22-069925
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 5.03, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalon GloboCare to acquire 60% of Laboratory Services MSO for up to $31M; appoints Sarah Cox as COO
--------------------------------------------------------------------------------

- Up to $31M total consideration: $5M prepaid, $10M cash at close, $15M in Series B Preferred (convertible at $0.575/sh), $1M anniversary payment, plus earnouts up to $10M.
- Private placement of Series A Preferred raises $5M; additional $10M issuance planned to fund remaining cash portion.
- Sarah Cox (CEO of Lab MSO) appointed COO of Avalon and director; Meng Li resigns as director.
- Closing expected in ~30 days, subject to financing and stockholder approval for conversion shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/0001213900-22-069925-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630212/000121390022069925/ea167589-8k_avalonglob.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-069925

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer